Massimo Santoro

Vandetanib in Patients With Locally Advanced or Metastatic Medullary Thyroid Cancer: A Randomized, Double-Blind Phase III Trial

Samuel A. Wells, Bruce G. Robinson, Robert F. Gagel et al. · Journal of Clinical Oncology · 2011 · 1.6K citations · Full text

Medicine, Oncology, Pharmacology +6

BRAF Mutations in Thyroid Tumors Are Restricted to Papillary Carcinomas and Anaplastic or Poorly Differentiated Carcinomas Arising from Papillary Carcinomas

Marina N. Nikiforova, Edna Teruko Kimura, Manoj Gandhi et al. · The Journal of Clinical Endocrinology & Metabolism · 2003 · 1.1K citations · Full text

Medicine, Genetics, Oncology +17

PTC is a novel rearranged form of the ret proto-oncogene and is frequently detected in vivo in human thyroid papillary carcinomas

Michèle Grieco, Massimo Santoro, Maria Teresa Berlingieri et al. · Cell · 1990 · 963 citations

Medicine, Molecular Biology, Molecular Genetics +16

Association of BRAF V600E Mutation with Poor Clinicopathological Outcomes in 500 Consecutive Cases of Papillary Thyroid Carcinoma

Cristiana Lupi, Riccardo Giannini, Clara Ugolini et al. · The Journal of Clinical Endocrinology & Metabolism · 2007 · 393 citations · Full text

Medicine, Oncology, Pathology +17

Ret oncogene activation in human thyroid neoplasms is restricted to the papillary cancer subtype.

Massimo Santoro, Francesca Carlomagno, Ian Hay et al. · Journal of Clinical Investigation · 1992 · 392 citations · Full text

Medicine, Oncology, Pathology +17